VF
CDTX

Virtu Financial’s Cidara Therapeutics CDTX Stock Holding History

Virtu Financial’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,315
Closed -$413K – 1727
2025
Q3 		$413K Sell
4,315
-3,586
-45% -$229K 0.02% 632
2025
Q2 		$385K Buy
+7,901
New +$190K 0.02% 666
2024
Q1 		– Sell
-4,773
Closed -$76K – 1471
2023
Q4 		$76K Buy
4,773
+3,820
+401% +$61.4K 0.01% 1083
2023
Q3 		$18K Buy
+953
New +$18.7K ﹤0.01% 1028
2022
Q4 		– Sell
-1,044
Closed -$13K – 1670
2022
Q3 		$13K Sell
1,044
-250
-19% -$3.45K ﹤0.01% 1483
2022
Q2 		$13K Buy
+1,294
New +$16K ﹤0.01% 1398
2021
Q1 		– Sell
-579
Closed -$23K – 1636
2020
Q4 		$23K Buy
+579
New +$28.8K ﹤0.01% 1348
2019
Q4 		$90K Buy
+1,173
New +$53.7K 0.01% 1101
2019
Q3 		– Sell
-1,834
Closed -$62K – 1455
2019
Q2 		$62K Buy
+1,834
New +$76.2K ﹤0.01% 1209
2018
Q2 		– Sell
-727
Closed -$58K – 2008
2018
Q1 		$58K Buy
+727
New +$99.3K ﹤0.01% 1683

Other funds holding CDTX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Virtu Financial's CDTX Position: Q4 2025 in Review

Virtu Financial sold out of Cidara Therapeutics (CDTX) in Q4 2025, closing a stake of 4,315 shares — an estimated $413K sold.

Virtu Financial first reported a position in CDTX in Q1 2018 and held it in 10 quarters. The position peaked at $413K in Q3 2025. 255 funds tracked by Wall St. Rank hold CDTX as of Q4 2025.

  • Virtu Financial reported no remaining Cidara Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Virtu Financial sold 4,315 Cidara Therapeutics shares in Q4 2025, an estimated $413K.
  • Virtu Financial first reported a position in Cidara Therapeutics in Q1 2018 and held it in 10 quarters.
  • Virtu Financial's Cidara Therapeutics position peaked at $413K in Q3 2025.
  • 255 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.